| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |